Literature DB >> 15860967

Renal cell carcinoma and hypertension.

Joel Handler1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15860967      PMCID： PMC8109699          DOI： 10.1111/j.1524-6175.2005.04108.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  8 in total

Review 1.  Diuretic therapy and renal cell carcinoma--another controversy?

Authors:  F H Messerli
Journal:  Eur Heart J       Date:  1999-10       Impact factor: 29.983

2.  Hypertension: a rare presentation of renal cell carcinoma.

Authors:  M R Moein; V O Dehghani
Journal:  J Urol       Date:  2000-12       Impact factor: 7.450

3.  Noradrenaline-producing renal-cell carcinoma: a unique cause of endocrine hypertension.

Authors:  M C Thomas; R J Walker; K Yun
Journal:  Nephrol Dial Transplant       Date:  1998-07       Impact factor: 5.992

4.  Obesity, hypertension, and the risk of kidney cancer in men.

Authors:  W H Chow; G Gridley; J F Fraumeni; B Järvholm
Journal:  N Engl J Med       Date:  2000-11-02       Impact factor: 91.245

5.  Renal cell carcinoma and malignant phase hypertension.

Authors:  P S Wong; G Y Lip; J C Gearty; D G Arkell; A J Howie; M A Ferreira; D G Beevers
Journal:  Blood Press       Date:  2001       Impact factor: 2.835

Review 6.  Bevacizumab for patients with metastatic renal cancer: an update.

Authors:  James C Yang
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

Review 7.  Renal cell carcinoma: unusual systemic manifestations.

Authors:  R E Cronin; W D Kaehny; P D Miller; D P Stables; P A Gabow; P R Ostroy; R W Schrier
Journal:  Medicine (Baltimore)       Date:  1976-07       Impact factor: 1.889

8.  Hypertension, obesity and their medications in relation to renal cell carcinoma.

Authors:  J M Yuan; J E Castelao; M Gago-Dominguez; R K Ross; M C Yu
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640
  8 in total
  1 in total

Review 1.  Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension.

Authors:  Zhengqing Ba; Ying Xiao; Ming He; Dong Liu; Hao Wang; Hanyang Liang; Jiansong Yuan
Journal:  Front Cardiovasc Med       Date:  2022-02-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.